Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $6.9700 (-0.57%) ($6.9700 - $6.9700) on Fri. Jul. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.8% (three month average) | RSI | 17 | Latest Price | $6.9700(-0.57%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BCRX declines -2.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(37%) BND(27%) VCIT(27%) IBB(25%) SHY(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.4% in a week (0% probabilities). XLRE(-30%) XLP(-24%) TBT(-21%) SPLV(-21%) DIA(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.4% (StdDev 2.8%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.21(-189.1%) | Resistance Level | $7.42 | 5 Day Moving Average | $7.02(-0.71%) | 10 Day Moving Average | $7.03(-0.85%) | 20 Day Moving Average | $7.42(-6.06%) | To recent high | -21.3% | To recent low | 0.4% | Market Cap | $1.23b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |